Specifically: North Dakota updated its essential health benefit (EHB) benchmark plan under the Affordable Care Act to require, beginning in 2025 , prescription drug coverage of GLP-1s and GIPs as therapy for prevention of diabetes and treatment of insulin resistance, metabolic syndrome or morbid obesity
This is the recommended solvent for the vast majority of injectable peptides
Who Should Avoid It AUTO-DENY for active cancer and chemotherapy patients

For gut health and inflammation BPC-157 - Critical for perimenopause: Why gut health matters in perimenopause: Estrogen decline worsens gut function Inflammation increases systemically IBS symptoms worsen Gut-hormone axis disrupted Stress affects gut dramatically How BPC-157 helps: Heals leaky gut and intestinal lining Reduces systemic inflammation Improves IBS and digestive issues Supports gut-brain axis (mood connection) Enhances overall health Dosing: 250-500mcg twice daily Injectable or oral (oral good for gut) 8-12 weeks minimum Can use long-term safely Benefits for perimenopause: Reduced bloating and digestive issues Lower inflammation (helps all symptoms) Better nutrient absorption Improved mood (gut-brain connection) Enhanced energy See our BPC-157 guide , BPC-157 benefits , how to take BPC-157 , is BPC-157 banned , BPC-157 5mg dosing guide , BPC-157 dosage calculator , BPC-157 vs TB-500 , BPC-157 alternatives , and peptides for gut health

Treatment Options at Calibrate Calibrate prescribes only FDA-approved GLP-1 medications